Side-by-side comparison of AI visibility scores, market position, and capabilities
Arlington VA aerospace and defense conglomerate (NYSE: RTX) at $80.7B 2024 sales (+9%) with $218B backlog; Collins Aerospace/Pratt & Whitney/Raytheon segments and 2025 guidance of $83-84B competing with Lockheed Martin.
RTX Corporation is an Arlington, Virginia-based global aerospace and defense technology company — publicly traded on the New York Stock Exchange (NYSE: RTX) as an S&P 500 and Dow Jones Industrial Average component — operating as the world's second-largest aerospace and defense company by sales through three business segments: Collins Aerospace (avionics, aerostructures, and aerospace systems), Pratt & Whitney (commercial and military jet engines), and Raytheon (defense systems including missiles, air defense, and cybersecurity). RTX was formed through the April 2020 merger of United Technologies Corporation (founded 1929) and Raytheon Company (founded 1922), and renamed from Raytheon Technologies to RTX in July 2023. In fiscal year 2024, RTX reported sales of $80.7 billion (+9% year-over-year), adjusted EPS of $5.73 (+13%), and free cash flow of $6.6 billion. RTX provided 2025 guidance of $83-84 billion in sales and $6.00-$6.15 adjusted EPS, reflecting 4-6% organic growth. The company employs approximately 185,000 people worldwide and maintains a combined $218 billion backlog ($125 billion commercial, $93 billion defense).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.